US2011223659A1PendingUtilityA1

Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus

Assignee: DIAGNOSTIC HYBRIDS INCPriority: Nov 3, 2003Filed: Dec 7, 2010Published: Sep 15, 2011
Est. expiryNov 3, 2023(expired)· nominal 20-yr term from priority
C12Q 1/701C12N 2770/20011
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus.

Claims

exact text as granted — not AI-modified
1 - 54 . (canceled) 
     
     
         55 . A method for inhibition of human coronavirus 229E replication comprising:
 i) providing a composition comprising the protease inhibitor E64D and Captisol; and   ii) contacting a cell permissive for 229E replication with said composition under conditions suitable for inhibiting 229E replication in said cell.   
     
     
         56 - 67 . (canceled) 
     
     
         68 . The method of  claim 55 , wherein said cell permissive for 229E replication is selected from the group consisting of a human embryonic kidney (HEK)-293 cell, a HEK-293T cell, a Huh-7 cell, a mink lung cell, a Mv1Lu cell, a primary rhesus monkey kidney (pRHMK) cell and a primary cynomolgus monkey kidney (pCMK) cell

Join the waitlist — get patent alerts

Track US2011223659A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.